The Best Central Centrifugal Scarring Alopecia Discussion You've Ever Heard

Central Centrifugal Cicatricial Alopecia (CCCA) management requires a shift from focusing solely on hair regrowth to prioritizing disease stability and inflammation reduction. The C-CAT (CCCA Clinical Assessment Tool) provides a quantitative framework to track disease activity, including pruritus, erythema, and scalp resistance, helping clinicians determine when to taper treatments. Emerging evidence supports the use of low-dose doxycycline for its anti-inflammatory and anti-fibrotic properties, alongside topical metformin, which activates AMPK to address fibrotic processes. Patients with CCCA often exhibit hyperinsulinemia, making HOMA-IR testing a critical diagnostic step for younger patients who may present with normal A1C levels. Addressing metabolic health, particularly insulin resistance, offers a promising pathway for managing CCCA, as systemic metabolic disturbances frequently drive the fibrotic progression characteristic of this condition.